TP53 and glioblastoma: MEG3 expression was found to be significantly reduced in glioblastoma due to DNA methyltransferase I-mediated hypermethylation of the MEG3 promoter, which downregulated MEG3 expression in glioblastoma and inhibited p53 protein activation.